 | • レポートコード：QYR9ST14691 • 出版社/出版日：QYResearch / 2019年9月10日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、CD40リガンドの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ISF-35、LOAd-700、MEDI-4920、MegaCD40L、その他に、用途別には、B型肝炎、膀胱がん、肝臓がん、卵巣がん、その他にセグメント区分し、CD40リガンドの世界市場を分析しました。 ・エグゼクティブ・サマリー ・CD40リガンドの世界市場概要 ・CD40リガンドの製造コスト構成分析 ・CD40リガンドの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・CD40リガンドの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・CD40リガンドのセグメント分析（種類別） （ISF-35、LOAd-700、MEDI-4920、MegaCD40L、その他） ・CD40リガンドのセグメント分析（用途別） （B型肝炎、膀胱がん、肝臓がん、卵巣がん、その他） ・CD40リガンドの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Biogen, Inc.、Bristol-Myers Squibb Company、eTheRNA Immunotherapies NV、ImmuNext, Inc.、Juno Therapeutics Inc.、MedImmune, LLC、Targovax AS、XL-protein GmbH） ・CD40リガンドの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global CD40 Ligand market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on CD40 Ligand volume and value at global level, regional level and company level. From a global perspective, this report represents overall CD40 Ligand market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of CD40 Ligand in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their CD40 Ligand manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Biogen, Inc.
Bristol-Myers Squibb Company
eTheRNA Immunotherapies NV
ImmuNext, Inc.
Juno Therapeutics Inc.
MedImmune, LLC
Targovax AS
XL-protein GmbH
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
ISF-35
LOAd-700
MEDI-4920
MegaCD40L
Others
Segment by Application
Hepatitis B
Bladder Cancer
Liver Cancer
Ovarian Cancer
Others
Table of Contents
Executive Summary
1 Industry Overview of CD40 Ligand
1.1 Definition of CD40 Ligand
1.2 CD40 Ligand Segment by Type
1.2.1 Global CD40 Ligand Production Growth Rate Comparison by Types (2014-2025)
1.2.2 ISF-35
1.2.3 LOAd-700
1.2.4 MEDI-4920
1.2.5 MegaCD40L
1.2.6 Others
1.3 CD40 Ligand Segment by Applications
1.3.1 Global CD40 Ligand Consumption Comparison by Applications (2014-2025)
1.3.2 Hepatitis B
1.3.3 Bladder Cancer
1.3.4 Liver Cancer
1.3.5 Ovarian Cancer
1.3.6 Others
1.4 Global CD40 Ligand Overall Market
1.4.1 Global CD40 Ligand Revenue (2014-2025)
1.4.2 Global CD40 Ligand Production (2014-2025)
1.4.3 North America CD40 Ligand Status and Prospect (2014-2025)
1.4.4 Europe CD40 Ligand Status and Prospect (2014-2025)
1.4.5 China CD40 Ligand Status and Prospect (2014-2025)
1.4.6 Japan CD40 Ligand Status and Prospect (2014-2025)
1.4.7 Southeast Asia CD40 Ligand Status and Prospect (2014-2025)
1.4.8 India CD40 Ligand Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of CD40 Ligand
2.3 Manufacturing Process Analysis of CD40 Ligand
2.4 Industry Chain Structure of CD40 Ligand
3 Development and Manufacturing Plants Analysis of CD40 Ligand
3.1 Capacity and Commercial Production Date
3.2 Global CD40 Ligand Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of CD40 Ligand
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 CD40 Ligand Production and Capacity Analysis
4.2 CD40 Ligand Revenue Analysis
4.3 CD40 Ligand Price Analysis
4.4 Market Concentration Degree
5 CD40 Ligand Regional Market Analysis
5.1 CD40 Ligand Production by Regions
5.1.1 Global CD40 Ligand Production by Regions
5.1.2 Global CD40 Ligand Revenue by Regions
5.2 CD40 Ligand Consumption by Regions
5.3 North America CD40 Ligand Market Analysis
5.3.1 North America CD40 Ligand Production
5.3.2 North America CD40 Ligand Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America CD40 Ligand Import and Export
5.4 Europe CD40 Ligand Market Analysis
5.4.1 Europe CD40 Ligand Production
5.4.2 Europe CD40 Ligand Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe CD40 Ligand Import and Export
5.5 China CD40 Ligand Market Analysis
5.5.1 China CD40 Ligand Production
5.5.2 China CD40 Ligand Revenue
5.5.3 Key Manufacturers in China
5.5.4 China CD40 Ligand Import and Export
5.6 Japan CD40 Ligand Market Analysis
5.6.1 Japan CD40 Ligand Production
5.6.2 Japan CD40 Ligand Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan CD40 Ligand Import and Export
5.7 Southeast Asia CD40 Ligand Market Analysis
5.7.1 Southeast Asia CD40 Ligand Production
5.7.2 Southeast Asia CD40 Ligand Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia CD40 Ligand Import and Export
5.8 India CD40 Ligand Market Analysis
5.8.1 India CD40 Ligand Production
5.8.2 India CD40 Ligand Revenue
5.8.3 Key Manufacturers in India
5.8.4 India CD40 Ligand Import and Export
6 CD40 Ligand Segment Market Analysis (by Type)
6.1 Global CD40 Ligand Production by Type
6.2 Global CD40 Ligand Revenue by Type
6.3 CD40 Ligand Price by Type
7 CD40 Ligand Segment Market Analysis (by Application)
7.1 Global CD40 Ligand Consumption by Application
7.2 Global CD40 Ligand Consumption Market Share by Application (2014-2019)
8 CD40 Ligand Major Manufacturers Analysis
8.1 Biogen, Inc.
8.1.1 Biogen, Inc. CD40 Ligand Production Sites and Area Served
8.1.2 Biogen, Inc. Product Introduction, Application and Specification
8.1.3 Biogen, Inc. CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company CD40 Ligand Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Company CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 eTheRNA Immunotherapies NV
8.3.1 eTheRNA Immunotherapies NV CD40 Ligand Production Sites and Area Served
8.3.2 eTheRNA Immunotherapies NV Product Introduction, Application and Specification
8.3.3 eTheRNA Immunotherapies NV CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 ImmuNext, Inc.
8.4.1 ImmuNext, Inc. CD40 Ligand Production Sites and Area Served
8.4.2 ImmuNext, Inc. Product Introduction, Application and Specification
8.4.3 ImmuNext, Inc. CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Juno Therapeutics Inc.
8.5.1 Juno Therapeutics Inc. CD40 Ligand Production Sites and Area Served
8.5.2 Juno Therapeutics Inc. Product Introduction, Application and Specification
8.5.3 Juno Therapeutics Inc. CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 MedImmune, LLC
8.6.1 MedImmune, LLC CD40 Ligand Production Sites and Area Served
8.6.2 MedImmune, LLC Product Introduction, Application and Specification
8.6.3 MedImmune, LLC CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Targovax AS
8.7.1 Targovax AS CD40 Ligand Production Sites and Area Served
8.7.2 Targovax AS Product Introduction, Application and Specification
8.7.3 Targovax AS CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 XL-protein GmbH
8.8.1 XL-protein GmbH CD40 Ligand Production Sites and Area Served
8.8.2 XL-protein GmbH Product Introduction, Application and Specification
8.8.3 XL-protein GmbH CD40 Ligand Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
9 Development Trend of Analysis of CD40 Ligand Market
9.1 Global CD40 Ligand Market Trend Analysis
9.1.1 Global CD40 Ligand Market Size (Volume and Value) Forecast 2019-2025
9.2 CD40 Ligand Regional Market Trend
9.2.1 North America CD40 Ligand Forecast 2019-2025
9.2.2 Europe CD40 Ligand Forecast 2019-2025
9.2.3 China CD40 Ligand Forecast 2019-2025
9.2.4 Japan CD40 Ligand Forecast 2019-2025
9.2.5 Southeast Asia CD40 Ligand Forecast 2019-2025
9.2.6 India CD40 Ligand Forecast 2019-2025
9.3 CD40 Ligand Market Trend (Product Type)
9.4 CD40 Ligand Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 CD40 Ligand Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of CD40 Ligand
Table Global CD40 Ligand Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global CD40 Ligand Production Market Share by Types in 2018
Figure ISF-35 Product Picture
Figure LOAd-700 Product Picture
Figure MEDI-4920 Product Picture
Figure MegaCD40L Product Picture
Figure Others Product Picture
Table Global CD40 Ligand Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global CD40 Ligand Consumption Market Share by Applications in 2018
Figure Hepatitis B
Figure Bladder Cancer
Figure Liver Cancer
Figure Ovarian Cancer
Figure Others
Figure Global CD40 Ligand Revenue (Million USD) (2014-2025)
Figure Global CD40 Ligand Production (K Pcs) (2014-2025)
Figure North America CD40 Ligand Market Size (Million USD) (2014-2025)
Figure Europe CD40 Ligand Market Size (Million USD) (2014-2025)
Figure China CD40 Ligand Market Size (Million USD) (2014-2025)
Figure Japan CD40 Ligand Market Size (Million USD) (2014-2025)
Figure Southeast Asia CD40 Ligand Market Size (Million USD) (2014-2025)
Figure India CD40 Ligand Market Size (Million USD) (2014-2025)
Table CD40 Ligand Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of CD40 Ligand in 2018
Figure Manufacturing Process Analysis of CD40 Ligand
Figure Industry Chain Structure of CD40 Ligand
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global CD40 Ligand Manufacturing Plants Distribution
Table CD40 Ligand Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table CD40 Ligand Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table CD40 Ligand Production (K Pcs) of Major Manufacturers (2014-2019)
Table CD40 Ligand Production Market Share of Major Manufacturers (2014-2019)
Figure CD40 Ligand Production Share by Manufacturers in 2018
Table CD40 Ligand Revenue (Million US$) of Major Manufacturers (2014-2019)
Table CD40 Ligand Revenue Market Share of Major Manufacturers (2014-2019)
Figure CD40 Ligand Revenue Share by Manufacturers in 2018
Table CD40 Ligand Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global CD40 Ligand Production by Regions 2014-2019 (K Pcs)
Table Global CD40 Ligand Production Market Share by Regions 2014-2019
Figure Global CD40 Ligand Production Market Share by Regions in 2018
Table Global CD40 Ligand Revenue by Regions 2014-2019 (Million USD)
Table Global CD40 Ligand Revenue Market Share by Regions 2014-2019
Figure Global CD40 Ligand Revenue Market Share by Regions in 2018
Table Global CD40 Ligand Consumption by Regions 2014-2019 (K Pcs)
Table Global CD40 Ligand Consumption Market Share by Regions 2014-2019
Figure North America CD40 Ligand Production Growth Rate 2014-2019 (K Pcs)
Figure North America CD40 Ligand Revenue Growth Rate 2014-2019 (Million USD)
Table North America CD40 Ligand Production, Consumption Import and Export (K Pcs)
Figure Europe CD40 Ligand Production Growth Rate 2014-2019 (K Pcs)
Figure Europe CD40 Ligand Revenue Growth Rate 2014-2019 (Million USD)
Table Europe CD40 Ligand Production, Consumption Import and Export (K Pcs)
Figure China CD40 Ligand Production Growth Rate 2014-2019 (K Pcs)
Figure China CD40 Ligand Revenue Growth Rate 2014-2019 (Million USD)
Table China CD40 Ligand Production, Consumption Import and Export (K Pcs)
Figure Japan CD40 Ligand Production Growth Rate 2014-2019 (K Pcs)
Figure Japan CD40 Ligand Revenue Growth Rate 2014-2019 (Million USD)
Table Japan CD40 Ligand Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia CD40 Ligand Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia CD40 Ligand Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia CD40 Ligand Production, Consumption Import and Export (K Pcs)
Figure India CD40 Ligand Production Growth Rate 2014-2019 (K Pcs)
Figure India CD40 Ligand Revenue Growth Rate 2014-2019 (Million USD)
Table India CD40 Ligand Production, Consumption Import and Export (K Pcs)
Figure Global Consumption CD40 Ligand Market Share by Application (2014-2019)
Figure Global Value (Consumption) CD40 Ligand Market Share by Application (2014-2019)
Table Biogen, Inc. CD40 Ligand Production Sites and Area Served
Table Biogen, Inc. CD40 Ligand Product Introduction, Application and Specification
Table Biogen, Inc. CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen, Inc. CD40 Ligand Production Growth Rate (2014-2019)
Table Biogen, Inc. CD40 Ligand Production Market Share (2014-2019)
Figure Biogen, Inc. CD40 Ligand Revenue Market Share (2014-2019)
Table Biogen, Inc. CD40 Ligand Main Business and Markets Served
Table Bristol-Myers Squibb Company CD40 Ligand Production Sites and Area Served
Table Bristol-Myers Squibb Company CD40 Ligand Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company CD40 Ligand Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company CD40 Ligand Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company CD40 Ligand Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company CD40 Ligand Main Business and Markets Served
Table eTheRNA Immunotherapies NV CD40 Ligand Production Sites and Area Served
Table eTheRNA Immunotherapies NV CD40 Ligand Product Introduction, Application and Specification
Table eTheRNA Immunotherapies NV CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table eTheRNA Immunotherapies NV CD40 Ligand Production Growth Rate (2014-2019)
Table eTheRNA Immunotherapies NV CD40 Ligand Production Market Share (2014-2019)
Figure eTheRNA Immunotherapies NV CD40 Ligand Revenue Market Share (2014-2019)
Table eTheRNA Immunotherapies NV CD40 Ligand Main Business and Markets Served
Table ImmuNext, Inc. CD40 Ligand Production Sites and Area Served
Table ImmuNext, Inc. CD40 Ligand Product Introduction, Application and Specification
Table ImmuNext, Inc. CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ImmuNext, Inc. CD40 Ligand Production Growth Rate (2014-2019)
Table ImmuNext, Inc. CD40 Ligand Production Market Share (2014-2019)
Figure ImmuNext, Inc. CD40 Ligand Revenue Market Share (2014-2019)
Table ImmuNext, Inc. CD40 Ligand Main Business and Markets Served
Table Juno Therapeutics Inc. CD40 Ligand Production Sites and Area Served
Table Juno Therapeutics Inc. CD40 Ligand Product Introduction, Application and Specification
Table Juno Therapeutics Inc. CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Juno Therapeutics Inc. CD40 Ligand Production Growth Rate (2014-2019)
Table Juno Therapeutics Inc. CD40 Ligand Production Market Share (2014-2019)
Figure Juno Therapeutics Inc. CD40 Ligand Revenue Market Share (2014-2019)
Table Juno Therapeutics Inc. CD40 Ligand Main Business and Markets Served
Table MedImmune, LLC CD40 Ligand Production Sites and Area Served
Table MedImmune, LLC CD40 Ligand Product Introduction, Application and Specification
Table MedImmune, LLC CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table MedImmune, LLC CD40 Ligand Production Growth Rate (2014-2019)
Table MedImmune, LLC CD40 Ligand Production Market Share (2014-2019)
Figure MedImmune, LLC CD40 Ligand Revenue Market Share (2014-2019)
Table MedImmune, LLC CD40 Ligand Main Business and Markets Served
Table Targovax AS CD40 Ligand Production Sites and Area Served
Table Targovax AS CD40 Ligand Product Introduction, Application and Specification
Table Targovax AS CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Targovax AS CD40 Ligand Production Growth Rate (2014-2019)
Table Targovax AS CD40 Ligand Production Market Share (2014-2019)
Figure Targovax AS CD40 Ligand Revenue Market Share (2014-2019)
Table Targovax AS CD40 Ligand Main Business and Markets Served
Table XL-protein GmbH CD40 Ligand Production Sites and Area Served
Table XL-protein GmbH CD40 Ligand Product Introduction, Application and Specification
Table XL-protein GmbH CD40 Ligand Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table XL-protein GmbH CD40 Ligand Production Growth Rate (2014-2019)
Table XL-protein GmbH CD40 Ligand Production Market Share (2014-2019)
Figure XL-protein GmbH CD40 Ligand Revenue Market Share (2014-2019)
Table XL-protein GmbH CD40 Ligand Main Business and Markets Served
Figure Global CD40 Ligand Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global CD40 Ligand Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global CD40 Ligand Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America CD40 Ligand Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America CD40 Ligand Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe CD40 Ligand Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe CD40 Ligand Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China CD40 Ligand Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China CD40 Ligand Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan CD40 Ligand Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan CD40 Ligand Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia CD40 Ligand Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia CD40 Ligand Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India CD40 Ligand Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India CD40 Ligand Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of CD40 Ligand by Type (2019-2025)
Table Global Consumption (K Pcs) of CD40 Ligand by Application (2019-2025)
Table CD40 Ligand Distributors List
Table CD40 Ligand Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Fc融合タンパク質の世界市場：市場規模・現状・予測 The Fc-Fusion Protein is a composition Fc domain of IgG which is genetically linked to a peptide/protein of interest.The restraining factors in the Fc-fusion protein market may be regulatory reforms of particular countries/ regions that restrict the sale or clinical trials of Fc-fusion in that regio…- ナルコレプシー療法の世界市場：市場規模・現状・予測 Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.In 2018, the global Narcolepsy Therapeutics market size was xx mil…
- 卵巣癌遺伝子治療の世界市場：市場規模・現状・予測 Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 膀胱がん治療の世界市場：市場規模・現状・予測 The bladder is an organ located in the lower abdominal region near the pelvic bones and acts as a reservoir of urine. A bladder cancer is characterized by the abnormal cell growth in the bladder, which impairs the proper functioning of urinary system. Majority of bladder cancer develops in the inner…
- 膀胱がん臨床試験の世界市場：市場規模・現状・予測 Bladder Cancer Clinical trials are research studies that involve people. The clinical trials on this list are for bladder cancer treatment. ... This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearb…